These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 11082533

  • 1. Increased production of very-low-density lipoproteins in transgenic mice overexpressing human apolipoprotein A-II and fed with a high-fat diet.
    Julve J, Escolà-Gil JC, Marzal-Casacuberta A, Ordóñez-Llanos J, González-Sastre F, Blanco-Vaca F.
    Biochim Biophys Acta; 2000 Nov 15; 1488(3):233-44. PubMed ID: 11082533
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate.
    Ribas V, Palomer X, Roglans N, Rotllan N, Fievet C, Tailleux A, Julve J, Laguna JC, Blanco-Vaca F, Escolà-Gil JC.
    Biochim Biophys Acta; 2005 Dec 15; 1737(2-3):130-7. PubMed ID: 16226489
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of human apolipoprotein A-II in mice induces hypertriglyceridemia due to defective very low density lipoprotein hydrolysis.
    Boisfer E, Lambert G, Atger V, Tran NQ, Pastier D, Benetollo C, Trottier JF, Beaucamps I, Antonucci M, Laplaud M, Griglio S, Chambaz J, Kalopissis AD.
    J Biol Chem; 1999 Apr 23; 274(17):11564-72. PubMed ID: 10206963
    [Abstract] [Full Text] [Related]

  • 5. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U.
    Exp Clin Endocrinol Diabetes; 2003 Aug 23; 111(5):246-50. PubMed ID: 12951628
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Overexpression of apolipoprotein E3 in transgenic rabbits causes combined hyperlipidemia by stimulating hepatic VLDL production and impairing VLDL lipolysis.
    Huang Y, Ji ZS, Brecht WJ, Rall SC, Taylor JM, Mahley RW.
    Arterioscler Thromb Vasc Biol; 1999 Dec 23; 19(12):2952-9. PubMed ID: 10591675
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J, Escolà-Gil JC, Rotllan N, Fiévet C, Vallez E, de la Torre C, Ribas V, Sloan JH, Blanco-Vaca F.
    Arterioscler Thromb Vasc Biol; 2010 Feb 23; 30(2):232-8. PubMed ID: 19910634
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of human apoAII in transgenic rabbits leads to dyslipidemia: a new model for combined hyperlipidemia.
    Koike T, Kitajima S, Yu Y, Li Y, Nishijima K, Liu E, Sun H, Waqar AB, Shibata N, Inoue T, Wang Y, Zhang B, Kobayashi J, Morimoto M, Saku K, Watanabe T, Fan J.
    Arterioscler Thromb Vasc Biol; 2009 Dec 23; 29(12):2047-53. PubMed ID: 19778946
    [Abstract] [Full Text] [Related]

  • 13. In vivo evidence of defective postprandial and postabsorptive free fatty acid metabolism in familial combined hyperlipidemia.
    Meijssen S, Cabezas MC, Twickler TB, Jansen H, Erkelens DW.
    J Lipid Res; 2000 Jul 23; 41(7):1096-102. PubMed ID: 10884291
    [Abstract] [Full Text] [Related]

  • 14. ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance.
    Escolà-Gil JC, Julve J, Marzal-Casacuberta A, Ordóñez-Llanos J, González-Sastre F, Blanco-Vaca F.
    J Lipid Res; 2001 Feb 23; 42(2):241-8. PubMed ID: 11181754
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
    Jong MC, Dahlmans VE, van Gorp PJ, van Dijk KW, Breuer ML, Hofker MH, Havekes LM.
    J Clin Invest; 1996 Nov 15; 98(10):2259-67. PubMed ID: 8941642
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia.
    Huang Y, Liu XQ, Rall SC, Taylor JM, von Eckardstein A, Assmann G, Mahley RW.
    J Biol Chem; 1998 Oct 09; 273(41):26388-93. PubMed ID: 9756870
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
    Zhong S, Goldberg IJ, Bruce C, Rubin E, Breslow JL, Tall A.
    J Clin Invest; 1994 Dec 09; 94(6):2457-67. PubMed ID: 7989603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.